A review of picotamide in the reduction of cardiovascular events in diabetic patients

References

• Antithrombotic Trialist’s CollaborationCollaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patientsBMJ2002324718611786451
   PubMedGoogle Scholar
• BalsanoFVioliFEffect of picotamide on the clinical progression of peripheral vascular disease. A double-blind placebo-controlled study. The ADEP GroupCirculation199387156398491012
   PubMed Web of Science ®Google Scholar
• BerrettiniMDe CuntoMPariseP“In vitro” and “ex vivo” effects of picotamide, a combined thromboxane A2-synthase inhibitor and -receptor antagonist, on human plateletsEur J Clin Pharmacol1990394955001963845
   PubMed Web of Science ®Google Scholar
• CaugheyGEClelandLGPenglisPSRoles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2J Immunol20011672831811509629
   PubMed Web of Science ®Google Scholar
• ChuaCCHamdyRCChuaBHRegulation of endothelin-1 production by a thromboxane A2 mimetic in rat heart smooth muscle cellsBiochim Biophys Acta19961313158781542
   PubMed Web of Science ®Google Scholar
• ClagettGPSobelMJacksonMRLipGYHAntithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on antithrombotic and thrombolytic therapyChest200426609S26S15383487
   PubMedGoogle Scholar
• CocozzaMPicanoTOlivieroUEffects of picotamide, an antithromboxane agent, on carotid atherosclerotic evolution. A two-year, double-blind, placebo-controlled study in diabetic patientsStroke19955976017709404
   PubMed Web of Science ®Google Scholar
• CsiszarAStefGPacherPOxidative stress-induced isoprostane formation may contribute to aspirin resistance in plateletsProstaglandin, Leukot Essent Fatty Acid2002665578
   PubMed Web of Science ®Google Scholar
• CyrusTYaoYDingTThromboxane receptor blockade improves the anti-atherogenic effect of thromboxane A2 suppression in LDLR KO miceBlood2006 Dec 7. (Epub ahead of print)
   PubMed Web of Science ®Google Scholar
• DavìGGreselePVioliFDiabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial diseaseCirculation19979669759236419
   PubMed Web of Science ®Google Scholar
• Di MinnoGVioliFAspirin resistance and diabetic angiopathy: back to the futureThromb Res200411397915115664
   PubMed Web of Science ®Google Scholar
• FitzGeraldGAMechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonistsAm J Cardiol19916811B15B
   PubMed Web of Science ®Google Scholar
• Food and Drug AdministrationInternal analgesic, antipyretic, and antirheumatic drug products for OTC human use: final rule for professional labeling of aspirin, buffered aspirin, and aspirin in combination with antacid drug productsFed Regist1998635680219
   Google Scholar
• GarciaMLMcNamaraPMGordonTMorbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up studyDiabetes197423105114359625
   PubMed Web of Science ®Google Scholar
• GiustinaAPeriniPDesenzaniPLong-term treatment with the dual antithromboxane agent picotamide decreases microalbuminuria in normotensive type 2 diabetic patientsDiabetes199847423309519749
   PubMed Web of Science ®Google Scholar
• GreselePMigliacciRPicotamide versus aspirin in diabetic patients with peripheral arterial disease: has David defeated Goliath?Eur Heart J20042517697115474690
   PubMedGoogle Scholar
• GreselePDeckmynHArnoutJCharacterization of N, N’-bis(3-picolyl)-4-methoxy-isophtalamide (picotamide) as a dual thromboxane synthase inhibitor/thromboxane A2 receptor antagonist in human plateletsThromb Haemost19896479842552606
   PubMedGoogle Scholar
• LandolfiRCastellanaMADe CristofaroREffect of picotamide on prostacyclin production by human endothelial cellsThromb Haemost1988605293070827
   PubMed Web of Science ®Google Scholar
• MilaniMLongoniAMadernaMEffects of picotamide, an antiplatelet agent, on cardiovascular, events in 438 claudicant patients with diabetes: a retrospective analysis of the ADEP studyBr J Clin Pharmacol19964278258971437
   PubMed Web of Science ®Google Scholar
• ModestiPACecioniIColellaABinding kinetics and antiplatelet activities of picotamide, a thromboxane A2 receptor antagonistBr J Pharmacol19941128168032666
   PubMed Web of Science ®Google Scholar
• ModestiPAColellaAAbbateRCompetitive inhibition of platelet thromboxane A2 receptor binding by picotamideEur J Pharmacol19894;16985932532145
   PubMed Web of Science ®Google Scholar
• ModestiPAColellaACecioniIAcute reduction of TxA2 platelet binding sites after in vivo administration of a TxA2 receptor inhibitorBr J Clin Pharmacol199131439431828683
   PubMed Web of Science ®Google Scholar
• Neri SerneriGGCoccheriSMarubiniEPicotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2year mortality in diabetics with peripheral arterial disease: the DAVID studyEur Heart J20042518455215474700
   PubMed Web of Science ®Google Scholar
• PanzramGMortality and survival in type 2 diabetes (non insulin dependent diabetes)Diabetologia198730123313556287
   PubMed Web of Science ®Google Scholar
• PariseLVVentonDLLe BretonGCArachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interactionJ Pharmacol Exp Ther198422824046319669
   PubMed Web of Science ®Google Scholar
• PatronoCFitzGeraldGAIsoprostanes: potential markers of oxidant stress in atherothrombotic diseaseArterioscler Thromb Vasc Biol1997172309159409197
   PubMed Web of Science ®Google Scholar
• RattiSQuaratoPCasagrandeCPicotamide, an antithromboxane agent, inhibits the migration and proliferation of arterial myocytesEur J Pharmacol199835577839754941
   PubMed Web of Science ®Google Scholar
• SaittaASardoABonaiutoMEffects of picotamide on release of endothelin-1, thromboxane and prostacycline after treadmill stress in patients with peripheral artery diseaseAngiology199849879909822043
   PubMed Web of Science ®Google Scholar
• VezzaRSpinaDTallaridaRJAntivasoconstrictor and antiaggregatory activities of picotamide unrelated to thromboxane A2 antagonismThromb Haemost1997781385919408024
   PubMed Web of Science ®Google Scholar
• VioliFGhiselliAIulianoLInhibition by picotamide of thromboxane production in vitro and ex vivoEur J Clin Pharmacol1988335996023366163
   PubMed Web of Science ®Google Scholar
• WAVE InvestigatorsThe effects of oral anticoagulants in patients with peripheral arterial disease: rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trialsAm Heart J20061511916368284
   PubMed Web of Science ®Google Scholar